Fate Therapeutics' FT819 Receives FDA RMAT Designation
A recent study highlights the potential of a new...
This week's must-know community updates, latest research & events
Apply now: feature your voice in our cell and gene therapy series
Obinutuzumab Shows Success in Phase 3 Lupus Nephritis Trial
Hormone therapy linked to increased SLE risk
Study Finds Predictors for Successfully Stopping Steroid Use in Lupus Patients
Rare Coexistence: Patient Diagnosed with Both Lupus and Type II Cryoglobulinemia
Selena Gomez on Her Lupus Diagnosis and Raising Awareness
NFL Stars Unite to Champion Lupus Awareness Through My Cause My Cleats
